Table 3.
Outcomes at 30 days and 90 days.
| Outcome | Intravenous r-tPA (n = 82) |
IA Thrombectomy (n = 31) |
Odds ratio (95% CI)* |
|---|---|---|---|
| mRankin score at 30 days, n (%) | |||
| 0–1 | 19 (23.2)† | 10 (32.3) | 1.58 (0.64 to 3.93) |
| 0–2 | 25 (30.5) | 15 (48.4) | 2.14 (0.92 to 4.99) |
| 3–5 | 29 (35.4) | 9 (29.0) | 0.75 (0.31 to 1.84) |
| 6 | 28 (34) | 7 (23) | 0.56 (0.22 to 1.47) |
| mRankin score at 90 days, n (%) | |||
| 0–1 | 22 (27.2) | 14 (45.2) | 2.25 (0.95 to 5.31) |
| 0–2 | 30 (37.0) | 17 (54.8) | 2.11 (0.91 to 4.87) |
| 3–5 | 20 (24.4) | 6 (19.4) | 0.74 (0.27 to 2.07) |
| 6 | 32 (39) | 8 (26) | 0.54 (0.22 to 1.36) |
| mRankin score at 90 days P value† | |||
| Median (IQR) | 4 (1 to 6) | 2 (1 to 6) | 0.065 |
| Case-fatality at 90 days, n (%) | 32 (39) | 8 (26) | 0.270 |
*Values were adjusted by logistic regression for age (categories), educational level, atrial fibrillation, NIHSS at admission (categories) and OCSP classification; †Mann–Whitney test.